Recruitment

Recruitment Status
Active, not recruiting
Estimated Enrollment
Same as current

Summary

Conditions
  • Crohn's Disease
  • IBD
Type
Interventional
Phase
Phase 2Phase 3
Design
Allocation: RandomizedIntervention Model: Parallel AssignmentMasking: Triple (Participant, Care Provider, Investigator)Primary Purpose: Treatment

Participation Requirements

Age
Between 16 years and 80 years
Gender
Both males and females

Description

Not Provided

Not Provided

Tracking Information

NCT #
NCT03759288
Collaborators
Not Provided
Investigators
Study Director: Kathy Bohannon AstraZeneca